Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06002425 · ClinicalTrials.gov registry record · NA
Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models
A NA study of Gastrointestinal Neoplasm Malignant, sponsored by Chinese Academy of Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 7
- Study locations
NCT06002425: Recruiting NA study of Gastrointestinal Neoplasm Malignant, sponsored by Chinese Academy of Sciences.
NCT06002425 is a NA study of Gastrointestinal Neoplasm Malignant that is actively recruiting participants, run by Chinese Academy of Sciences. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). The trial reports 7 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06002425, a NA study of Gastrointestinal Neoplasm Malignant, is actively recruiting participants, sponsored by Chinese Academy of Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study will evaluate the utility of ChatGPT in recommending treatment plans for patients with gastrointestinal cancers, using both retrospective and prospective data.
Primary Outcome
The percentage of the initial 100 participants and the overall participants in the ChatGPT-Assisted group whose treatment plans are adjusted by clinicians after consulting with ChatGPT.
Conditions Studied
Interventions
- OTHER Clinician-Directed Treatment Plan
- OTHER ChatGPT-Assisted Treatment Plan
Study Locations (7)
Guangdong
- Jiangmen Central Hospital - Jiangmen
- The Fifth Affiliated Hospital of Sun Yat-sen University - Zhuhai
- Zhuhai People's Hospital - Zhuhai
California
- City of Hope - Duarte
Inner Mongolia
- Peking University Cancer Hospital (Inner Mongolia Campus) - Hohhot
Saxony-Anhalt
- University Hospital Magdeburg - Magdeburg
Other
- San Raffaele University Hospital, Italy - Milan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2023-08-29 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT06002425 shows while recruiting
NCT06002425 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Gastrointestinal Neoplasm Malignant appearing as the primary indexed condition, and to 2 interventions - of which Clinician-Directed Treatment Plan is the first listed.
NCT06002425 lists 7 locations in 5 states (Guangdong, California, Inner Mongolia).
Frequently Asked Questions
What is clinical trial NCT06002425 about?
NCT06002425 is a clinical study titled "Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models". This study will evaluate the utility of ChatGPT in recommending treatment plans for patients with gastrointestinal cancers, using both retrospective and prospective data.
What is the current status of trial NCT06002425?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2023-08-29. Estimated completion is 2028-12-31.
What conditions does trial NCT06002425 study?
This clinical trial studies the following conditions: Gastrointestinal Neoplasm Malignant.
What interventions are being tested in trial NCT06002425?
The interventions under investigation include: Clinician-Directed Treatment Plan (OTHER), ChatGPT-Assisted Treatment Plan (OTHER).
Who is sponsoring clinical trial NCT06002425?
This trial is sponsored by Chinese Academy of Sciences, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06002425 being conducted?
This trial has 7 study locations across California, Guangdong, Inner Mongolia, Saxony-Anhalt. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrointestinal Neoplasm Malignant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06002425's enrollment target sits among peer trials
400 246th of 2000 higher than 1,734 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI